Adicon Holdings Limited

Equities

9860

KYG0086A1076

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 01:38:15 21/05/2026 pm IST			5-day change	1st Jan Change
4.530 ^HKD	+1.80%		+8.89%	+7.09%

31/03	Jefferies Adjusts Adicon Holdings' Price Target to HK$7 From HK$12.60, Keeps at Buy	MT
26/03	Adicon Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Tranche Update on Adicon Holdings Limited's Equity Buyback Plan announced on June 10, 2024.

Published on 08/30/2024 at 02:00 pm IST

S&P Capital IQ

ADICON HOLDINGS LIMITED

+1.80%

From June 7, 2024 to August 30, 2024, the company has repurchased 1,611,500 shares, representing 0.25% for HKD 15.42 million. With this, the company has completed the repurchase of 1,611,500 shares, representing 0.25% for HKD 15.42 million under the buyback announced on June 10, 2024.

Latest news about Adicon Holdings Limited

31/03	Jefferies Adjusts Adicon Holdings' Price Target to HK$7 From HK$12.60, Keeps at Buy	MT
26/03	Adicon Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
25/03	Adicon says FY profit attributable RMB18.4 million	RE
25/03	Adicon's Profit, Revenue Fall in 2025	MT
25/03	Adicon Holdings Limited acquired 10% stake in Astrabio.	CI
02/03	Adicon Holdings announces resignation of Gao Song as executive director, CEO	RE
02/03	Adicon Holdings Limited Announces Resignation of Executive Director and Strategy Committee Member Gao Song, Effective March 2, 2026	CI
02/03	Adicon Holdings Limited Announces CEO Changes, Effective March 20, 2026	CI
24/02	Adicon Holdings Limited Announces Board and Board Committee Changes, Effective February 24, 2026	CI
13/02	Adicon Holdings Limited Announces Appointment of Wang Legang as Executive Director and Member of Strategy Committee, Effective February 13, 2026	CI
13/02	Adicon Holdings appoints Wang Legang as executive director	RE
06/01	EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO	AN
14/11	Adicon Unit to Acquire Crown Bioscience for Up to $204 Million; Shares Fall 8%	MT
13/11	Adicon Holdings Limited entered into a definitive agreement to acquire Crown Bioscience, Inc. from Crown Bioscience International.	CI
09/11	ADICON Holdings Limited Announces Resignation of Zhu Jonathan as Non-Executive Director and Board Committee Member	CI

Chart Adicon Holdings Limited

Duration

Period

9860: Dynamic Chart

Company Profile

Adicon Holdings Ltd is a holding company mainly engaged in the provision of independent clinical laboratory (ICL) services. The Company is engaged in the provision of medical testing, clinical trials, scientific research services, health management and pathology consultation services. The Company focuses on the development of core disease areas such as infectious diseases, women's health, solid tumors, perinatal & children's centers, and blood, covering many subjects such as internal medicine, pediatrics, obstetrics and gynecology, oncology, and neurology.

Employees

5,071

Sector

Healthcare Facilities & Services

More about the company